Probiotic Role in Prevention of Ventilator Associated Pneumonia in Critically- Ill Children Admitted at Pediatric Intensive Care Unit
Condition(s) studied
Investigational drug(s) / intervention(s)
Probiotics: Critically ill ventilated children will receive standard management plus probiotics.
Standard management: Critically ill ventilated children will receive standard management only.
Study summary
The aim of the work is to evaluate the impact of Probiotics supplementation on prevention of ventilator associated pneumonia in critically ill children admitted at Pediatric Intensive Care Unit at Tanta University Hospitals.
Eligibility
Primary outcome measure(s)
- Incidence of ventilator-associated pneumonia — During the first 28 days after initiation of mechanical ventilation
Incidence of ventilator-associated pneumonia (VAP) diagnosed according to predefined CDC/NHSN pediatric criteria
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tanta University | Tanta | Al Gharbia | Recruiting |
More Tanta University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07848165 on ClinicalTrials.gov ↗ ← All trials in Egypt